TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

NOCTURNAL

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

NOCTURNAL

ST13

US500000097175653

Classe

35, 36, 42

Pedido

97175653

Registro

7141791

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

27

Atualização mais recente

22/08/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

35, 36, 42

Data de depósito

16/12/2021

Data de registro

22/08/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/08/2023

Última transação

22/08/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Primeiro uso

2012-04-00

Primeiro uso no comércio

2012-04-00

Código do desenho

4

Tipo de titular

16

Localização do titular

Durham, NC

Examinador

SIRIGNANO, EMMA

Unidade examinadora

M40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Nocturnal Product Development, LLC

Representantes

Devon E. White WYRICK ROBBINS YATES & PONTON LLP

Classificação técnica

Classes Nice

Classe 35Classe 36Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

business consulting services, namely, providing assistance in the development of innovation-driven business strategies and creative ideation; business consulting in the field of clinical trials, namely, assisting with clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies; business consulting services, namely, providing information to companies and universities on managing grant funding from federal, state, and local governments for clinical research and clinical trials; business consulting services, namely, maintaining design history files, performing business risk analysis, and planning and executing verification and validation activities that support clinical investigations in domestic and international settings, namely, providing independent review of clinical trials for business purposes, developing regulatory strategies for obtaining domestic and international approvals in the nature of clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with applications for drug and medical device approval, and assisting businesses in preparing and filing applications for and managing government grant funding in the field of medical devices and products; business consulting services, namely, assisting with clinical trial submissions, namely, regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and new medical devices with governmental regulatory bodies; business consulting services, namely, assisting in obtaining domestic and international approvals by developing regulatory strategies and authoring product approval and product registration submissions; business consulting services, namely, project management services to identify and mitigate potential risks in complex projects; business consulting services, namely, consultation in the fields of medical products and medical devices

Classe 36

business financial and funding consulting services, namely, providing information that advises companies and universities seeking to obtain grant funding from federal, state, and local governments for clinical research and clinical trials

Classe 42

product research and development in the fields of medical products and medical devices; mechanical engineering services for electronics packaging, structural finite element analysis, and thermal analysis; product design and development in the field of medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software to meet the demands of medical products and medical devices; product design and development in the field of medical devices, namely, electromagnetic compatibility (EMC) and electrical safety testing to meet the demands of international regulatory standards; product design and development in the field of medical products and medical devices, namely, development of laser systems, fiber and electro-optics, and biophotonics for spectroscopy and optical characterization of living tissue via both diffuse reflectance and fluorescence; cloud-based Platform as a Service (PaaS) featuring computer software platforms that communicate with and collect data from medical products and medical devices; product design and development in the field of medical products and medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software for use with medical products and medical devices including topical electronic medical devices, active electronic implants, implantable pacemakers, defibrillators, diagnostic catheters, ablation catheters, and neurostimulators; business product development consulting services, namely, providing assistance in the development of leading-edge technologies for medical, biopharmaceutical, and biotechnology companies

Publicações

Histórico de despachos e eventos da marca no USPTO.

27 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

22/08/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

22/08/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/06/2023

PUBO

PUBLISHED FOR OPPOSITION

06/06/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

17/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/05/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/04/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/04/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/04/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/04/2023

GNRT

NON-FINAL ACTION E-MAILED

07/04/2023

CNRT

NON-FINAL ACTION WRITTEN

07/04/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/03/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/03/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

22/12/2022

GNRT

NON-FINAL ACTION E-MAILED

22/12/2022

CNRT

NON-FINAL ACTION WRITTEN

22/12/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/11/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/11/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/11/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

26/09/2022

GNRT

NON-FINAL ACTION E-MAILED

26/09/2022

CNRT

NON-FINAL ACTION WRITTEN

26/09/2022

DOCK

ASSIGNED TO EXAMINER

22/09/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

21/12/2021

NWAP

NEW APPLICATION ENTERED

20/12/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace NOCTURNAL ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.